Articles related to BACTERIAL INFECTIONS

The guidelines introduce a significant shift in treatment duration, suggesting 10-14 days may be sufficient for uncomplicated cases showing rapid clinical improvement, challenging traditional 21-28 day courses.

The CDC investigation revealed that the 65 people who contracted Salmonella from the outbreak ranged from 2 to 88 years old, highlighting the wide demographic susceptibility to foodborne illnesses.

In Long Beach, a tuberculosis outbreak linked to a hotel has prompted emergency health measures, emphasizing the critical need for immediate and comprehensive response strategies in managing infectious disease outbreaks.

With a significant rise in meningococcal disease cases in 2023 and continuing into 2024, physicians must be alert for non-traditional symptoms such as septic arthritis and bacteremia to ensure timely and effective patient management.

Zevtera® (ceftobiprole medocaril) provides a significant advancement in treating serious bacterial infections, demonstrating high efficacy against both MRSA and MSSA in recent phase 3 clinical trials.

In the realm of otolaryngology, cholesteatoma presents a unique challenge, with a case study revealing a 4.6% recurrence rate and a 5.4% residual disease rate. Continuous monitoring is essential for effective management.